LT4910B - Skystakristalinio tirpiklio turinti dermatologinė kompozicija ir jos pagaminimo būdas - Google Patents
Skystakristalinio tirpiklio turinti dermatologinė kompozicija ir jos pagaminimo būdas Download PDFInfo
- Publication number
- LT4910B LT4910B LT2001079A LT2001079A LT4910B LT 4910 B LT4910 B LT 4910B LT 2001079 A LT2001079 A LT 2001079A LT 2001079 A LT2001079 A LT 2001079A LT 4910 B LT4910 B LT 4910B
- Authority
- LT
- Lithuania
- Prior art keywords
- weight
- homogenizer
- amount
- liquid
- active ingredient
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 18
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 239000004480 active ingredient Substances 0.000 claims abstract description 25
- 239000002904 solvent Substances 0.000 claims abstract description 24
- 239000002671 adjuvant Substances 0.000 claims abstract description 14
- 239000008346 aqueous phase Substances 0.000 claims abstract description 11
- 239000000645 desinfectant Substances 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004202 carbamide Substances 0.000 claims abstract description 8
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000013543 active substance Substances 0.000 claims abstract description 6
- 229960002206 bifonazole Drugs 0.000 claims abstract description 6
- 239000001540 sodium lactate Substances 0.000 claims abstract description 6
- 229940005581 sodium lactate Drugs 0.000 claims abstract description 6
- 235000011088 sodium lactate Nutrition 0.000 claims abstract description 6
- 229940045136 urea Drugs 0.000 claims abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 9
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 claims description 8
- 235000021355 Stearic acid Nutrition 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 8
- 238000000265 homogenisation Methods 0.000 claims description 8
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 claims description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 8
- 239000008117 stearic acid Substances 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 7
- 229940045860 white wax Drugs 0.000 claims description 7
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 claims description 6
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 claims description 6
- 229940098760 steareth-2 Drugs 0.000 claims description 6
- 229940100458 steareth-21 Drugs 0.000 claims description 6
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 claims description 5
- 229940078491 ppg-15 stearyl ether Drugs 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 238000004945 emulsification Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 claims description 2
- 229940085262 cetyl dimethicone Drugs 0.000 claims description 2
- 230000001804 emulsifying effect Effects 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims 4
- 230000000699 topical effect Effects 0.000 claims 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 230000001960 triggered effect Effects 0.000 claims 1
- 239000012071 phase Substances 0.000 abstract description 19
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 abstract description 4
- 239000007764 o/w emulsion Substances 0.000 abstract description 4
- 239000000176 sodium gluconate Substances 0.000 abstract description 4
- 235000012207 sodium gluconate Nutrition 0.000 abstract description 4
- 229940005574 sodium gluconate Drugs 0.000 abstract description 4
- 241000446313 Lamella Species 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 9
- 239000010410 layer Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- -1 compound compounds Chemical class 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000012874 anionic emulsifier Substances 0.000 description 1
- 239000012871 anti-fungal composition Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 150000008040 ionic compounds Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 230000002535 lyotropic effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000001907 polarising light microscopy Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0295—Liquid crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SK288-99A SK283697B6 (sk) | 1999-03-03 | 1999-03-03 | Dermatologické prípravky s tekutými kryštálmi ako vehikulom a spôsob ich prípravy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2001079A LT2001079A (en) | 2002-02-25 |
| LT4910B true LT4910B (lt) | 2002-04-25 |
Family
ID=20433382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2001079A LT4910B (lt) | 1999-03-03 | 2001-07-26 | Skystakristalinio tirpiklio turinti dermatologinė kompozicija ir jos pagaminimo būdas |
Country Status (8)
| Country | Link |
|---|---|
| BG (1) | BG65442B1 (pl) |
| CZ (1) | CZ295212B6 (pl) |
| HU (1) | HUP0200101A3 (pl) |
| LT (1) | LT4910B (pl) |
| LV (1) | LV12781B (pl) |
| PL (1) | PL198485B1 (pl) |
| SK (1) | SK283697B6 (pl) |
| WO (1) | WO2000051549A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1014389C2 (nl) * | 2000-02-15 | 2001-08-16 | Dija Zeist Bv | Bruiningspreparaat voor de huid. |
| DE10241541A1 (de) * | 2002-09-05 | 2004-03-18 | Nguyen-Petersen, Chanh-Dinh, Dr.med. | Creme für kosmetische Zwecke |
| US11191704B2 (en) | 2014-08-20 | 2021-12-07 | Amantin Experts | Compositions and methods for controlled moisturizing and release of active ingredients |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9010526D0 (en) * | 1990-05-10 | 1990-07-04 | Unilever Plc | Cosmetic composition |
| CA2168543A1 (en) * | 1993-07-03 | 1995-02-09 | George Endel Deckner | Personal cleansing compositions |
| FR2725897B1 (fr) * | 1994-10-24 | 1996-12-06 | Oreal | Produit pour application topique contenant une lipase et un precurseur d'actif |
-
1999
- 1999-03-03 SK SK288-99A patent/SK283697B6/sk not_active IP Right Cessation
- 1999-12-28 HU HU0200101A patent/HUP0200101A3/hu unknown
- 1999-12-28 WO PCT/SK1999/000017 patent/WO2000051549A1/en not_active Ceased
- 1999-12-28 PL PL350141A patent/PL198485B1/pl unknown
- 1999-12-28 CZ CZ20013092A patent/CZ295212B6/cs not_active IP Right Cessation
-
2001
- 2001-07-26 LT LT2001079A patent/LT4910B/lt not_active IP Right Cessation
- 2001-08-29 BG BG105852A patent/BG65442B1/bg unknown
- 2001-10-02 LV LV010141A patent/LV12781B/xx unknown
Non-Patent Citations (3)
| Title |
|---|
| MILAN CHALABALA ET AL.: "Technologie léků - galenika" |
| S. FRIBERG: "Three-phase emulsion", J. SOC. COSMET. CHEM., 1979, pages 309 - 319 |
| TOSHIYUKI SUZUKI, HIROKO TAKEI, SEIJI YAMAZAK: "Formation of fine three-phase emulsions by the liquid crystal emulsification method with arginine β-branched monoalkyl phosphate", JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1989, pages 491 - 500, XP024208623, DOI: doi:10.1016/0021-9797(89)90463-3 |
Also Published As
| Publication number | Publication date |
|---|---|
| LV12781B (lv) | 2002-04-20 |
| CZ295212B6 (cs) | 2005-06-15 |
| HUP0200101A2 (en) | 2002-06-29 |
| BG105852A (en) | 2002-04-30 |
| PL350141A1 (en) | 2002-11-04 |
| PL198485B1 (pl) | 2008-06-30 |
| HUP0200101A3 (en) | 2006-07-28 |
| SK283697B6 (sk) | 2003-12-02 |
| CZ20013092A3 (cs) | 2002-01-16 |
| LT2001079A (en) | 2002-02-25 |
| SK28899A3 (en) | 2000-09-12 |
| LV12781A (en) | 2002-01-20 |
| BG65442B1 (bg) | 2008-08-29 |
| WO2000051549A1 (en) | 2000-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eccleston | Functions of mixed emulsifiers and emulsifying waxes in dermatological lotions and creams | |
| Kreuter | Colloidal drug delivery systems | |
| US7008646B2 (en) | Cubic liquid crystalline compositions and methods for their preparation | |
| US4699924A (en) | Skin treatment composition | |
| CA2411918C (en) | Cubic liquid crystalline compositions and methods for their preparation | |
| EP2604253A1 (en) | Water-in-oil emulsions and methods for their preparation | |
| EA021149B1 (ru) | Косметические или дерматологические пенные составы, их применение и способы получения | |
| PT1545757E (pt) | Emulsões perfluorcarbonadas com tensioactivos não fluorados | |
| KR20090088954A (ko) | 세라마이드를 포함하는 유중수 유화제 형태의 피부 외용제 | |
| Chellapa et al. | Nanoemulsion for cosmetic application | |
| Eccleston | Emulsions and creams | |
| CN105213207B (zh) | 一种磷脂表面活性剂多重结构脂质体及其制备方法 | |
| Scherlund et al. | Stabilization of a thermosetting emulsion system using ionic and nonionic surfactants | |
| KR100836035B1 (ko) | 포화 및 불포화 레시틴 함유 나노에멀젼 및 이를 함유하는화장료 조성물 | |
| Junginger | Ointments and creams as colloidal drug delivery systems | |
| LT4910B (lt) | Skystakristalinio tirpiklio turinti dermatologinė kompozicija ir jos pagaminimo būdas | |
| Tambade et al. | Formulation and evaluation of novel gel containing liquid crystals of naproxen | |
| KR101776173B1 (ko) | 경피 투과를 증진시키는 액정구조를 포함하는 수중유형 화장료 조성물 | |
| Spicer | Cubosome formation via dilution: Kinetic effects and consumer product implications | |
| Junginger | Pharmaceutical emulsions and creams | |
| KR101507886B1 (ko) | 리포아미노산을 함유한 리파좀 캡슐 조성물, 그의 제조방법 및 그를 함유한 화장료 조성물 | |
| KR100530107B1 (ko) | 액정막 유화 화장료 조성물 및 그의 제조방법 | |
| KR102551533B1 (ko) | 다층구조를 가지는 피부활성물질 전달체 제조방법 | |
| Fanun | Sugar esters microemulsions | |
| Mahale et al. | Review On: Liquid Crystal Cream for Topical Drug Delivery. Trends in Drug Delivery. 2024; 11 (1): 1–8p |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD9A | Change of patent owner |
Owner name: ZENTIVA. A.S., SK Effective date: 20041208 |
|
| MK9A | Expiry of a patent |
Effective date: 20191228 |